person · Reporting owner
KRAEMER HARRY M JANSEN JR
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 12, 2024 | January 16, 2024 |
| Leidos Holdings, Inc.LDOS · Entity 668 | Director | October 07, 2026 | October 09, 2026 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 12, 2024 · Filed January 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,351.467 |
Reported balance
After 2024-01-12 transaction · row 1
1 source rowRow 1 · 2024-01-12 · Grant · Acquired 46.076 · Balance 148,351.467 F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 2,758.1977 |
Reported balance
After 2024-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-12 · Grant · Acquired 10.4546 · Balance 2,758.1977 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Leidos Holdings, Inc.
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Key Executive Stock Deferral Plan | 132,108.0146 |
Reported balance
After 2026-10-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 297.2259 · Balance 132,108.0146 F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. |
| Common StockSEC Table I · non-derivative | Direct | 93,281 |
Reported balance
Holding disclosure · report date 2026-10-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 93,281 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 471,076 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 458,997 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 12,079 · Balance 471,076 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VWR Corp
Report date November 21, 2017 · Filed November 22, 2017
Section 16 reporting ended · disclosed 2017-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 1
1 source rowRow 1 · 2017-11-21 · Disposition to issuer · Disposed 7,617 · Balance 0 F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. |
| Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.00 · Expires 2021-10-01 | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-21 · Disposition to issuer · Disposed 22,617 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.
F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2021 Filed May 12, 2021 21:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,685 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0001628280-21-010055 · wf-form4_162085572269799.xml · derivative · entry 4 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,685 shares Expires 2021-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was previously reported as a stock option grant for 8,636 shares of common stock at an exercise price of $39.03 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. This stock option was incorrectly reported previously as allocated to indirect holdings through the issuer's Key Executive Stock Deferral Plan. F2 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 8,636 shares of common stock at an exercise price of $39.03 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. This stock option was incorrectly reported previously as allocated to indirect holdings through the issuer's Key Executive Stock Deferral Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 3,240 | $104.03 | $337,057.20 |
DisclosureSEC source: 0001628280-21-010055 · wf-form4_162085572269799.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,277 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 11,685 | $28.84 | $337,043.31 |
DisclosureSEC source: 0001628280-21-010055 · wf-form4_162085572269799.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 12, 2021 00:25 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 2,123 | $0.00 Strike: $103.90 | $0.00 |
DisclosureSEC source: 0001628280-21-009899 · wf-form4_162077908889846.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,123 Underlying: Common Stock · 2,123 shares Expires 2028-05-06 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 07, 2021 Filed May 12, 2021 00:25 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-009899 · wf-form4_162077908889846.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 115,709.0191 Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:48 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 14.1234 | $100.82 | $1,423.92 |
DisclosureSEC source: 0001628280-21-008900 · wf-form4_162016127497515.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 114,650.0191 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 21:26 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 18.409 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013652 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,061.24 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 20:53 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 407.1706 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-006494 · wf-form4_161739677400566.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 114,635.8957 F1 · shares: Dividend equivalent rights. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:32 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 21.728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001504 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,042.831 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:14 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 377.3124 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-000129 · wf-form4_160989566843400.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 114,228.7251 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:36 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 25.902 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026850 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,021.103 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 23:22 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 429.8963 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-014224 · wf-form4_160168093937214.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 113,851.4127 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 10, 2020 Filed Jul 10, 2020 20:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 25.991 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021352 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,995.201 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:25 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 422.3775 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-010184 · wf-form4_159372510011565.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 113,421.5164 F1 · shares: Dividend equivalent rights. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:42 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 21,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-076450 · a4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,760 F1 · shares: The reporting person received an award of restricted stock units on June 22, 2020. The number of restricted stock units granted was calculated to reflect $294,500 of value based on the closing price of the issuer's common stock on May 22, 2020, the date of the annual meeting at which directors were elected. Read SEC document |
| May 21, 2020 Filed May 22, 2020 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017758 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,969.21 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 20, 2020 Filed May 21, 2020 20:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,251 | $97.82 Strike: $28.19 | $807,112.82 |
DisclosureSEC source: 0001628280-20-008221 · wf-form4_159009184308644.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,251 shares Expires 2020-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Relates to options granted June 7, 2013. Read SEC document |
| May 20, 2020 Filed May 21, 2020 20:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 2,379 | $97.82 | $232,713.78 |
DisclosureSEC source: 0001628280-20-008221 · wf-form4_159009184308644.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,832 F1 · shares: The transaction involved the surrender of shares to Leidos Holdings, Inc. to pay the exercise price and fees for options exercised. Read SEC document |
| May 20, 2020 Filed May 21, 2020 20:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 8,251 | $28.19 | $232,634.47 |
DisclosureSEC source: 0001628280-20-008221 · wf-form4_159009184308644.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2020 Filed May 12, 2020 21:47 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007600 · wf-form4_158932000820913.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 112,999.1389 Read SEC document |
| May 01, 2020 Filed May 4, 2020 20:41 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 18.9859 | $98.81 | $1,876.00 |
DisclosureSEC source: 0001628280-20-006256 · wf-form4_158862485867761.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 111,952.1389 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:17 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 16.939 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013697 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,203.21 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 22:37 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 441.2503 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-004711 · wf-form4_158621263044041.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 111,933.153 F1 · shares: Dividend equivalent rights. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:34 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11.283 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001556 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,186.271 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 21:21 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 387.4855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-015388 · wf-form4_157782726825159.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 111,491.9027 F1 · shares: Dividend equivalent rights. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 21:57 UTC | Option Care Health, Inc. BIOS · Entity 4126 | GrantCommon Stock, par value $0.0001 | 87,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-071882 · tm1924596d5_4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,910 Read SEC document |
| October 11, 2019 Filed Oct 16, 2019 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 12.106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030623 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,174.988 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 447.2699 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-012939 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 111,104.4172 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:47 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 9.584 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024637 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,162.882 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:28 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 449.0019 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009908 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 110,657.1473 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:50 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020156 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,153.298 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 3,345 | $0.00 Strike: $75.02 | $0.00 |
DisclosureSEC source: 0001225208-19-007958 · doc4.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 Underlying: Common Stock · 3,345 shares Expires 2026-05-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-007958 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 110,208.1454 Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 54,426 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017748 · form4.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,426 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 10,919 | $54.83 | $598,688.77 |
DisclosureSEC source: 0001127602-19-017748 · form4.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,897.298 Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 54,426 | $11.00 | $598,686.00 |
DisclosureSEC source: 0001127602-19-017748 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,816.298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person exercised the reported stock options, which would have expired on May 7, 2019, and holds the underlying net common stock upon exercise. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 21:40 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 30.5781 | $66.39 | $2,030.08 |
DisclosureSEC source: 0001225208-19-007351 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 108,808.1454 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.523 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015448 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,390.298 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:37 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 548.4612 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006134 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 108,777.5673 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:36 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,886 | $64.98 Strike: $25.10 | $707,372.28 |
DisclosureSEC source: 0001225208-19-004729 · doc4.xml · derivative · entry 4 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,886 shares Expires 2019-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Relates to options granted March 30, 2012. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:36 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 4,205 | $64.98 | $273,240.90 |
DisclosureSEC source: 0001225208-19-004729 · doc4.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,960 F1 · shares: Transaction involved the surrender of shares to Leidos Holdings, Inc. to pay the exercise price and fees for options exercised. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:36 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 10,886 | $25.10 | $273,216.83 |
DisclosureSEC source: 0001225208-19-004729 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:26 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.365 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002014 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,384.775 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 28, 2018 Filed Jan 2, 2019 22:35 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 660.9954 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000127 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 108,229.1061 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.223 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030311 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,377.41 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 21:19 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 505.3376 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-014168 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 107,568.1107 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 13, 2018 Filed Jul 13, 2018 20:43 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6.215 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023199 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,370.187 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:32 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 586.4031 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-011343 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 107,062.7731 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001127602-18-018827 · form4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2028-05-23 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018827 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,363.972 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.